PAPER Grillo SL, Duggett NA, Ennaceur A, Chazot PL
SEARCH RESULTS
329930 RESULTS
PAPER Di Domenico F, Coccia R, Cocciolo A, Murphy MP, Cenini G, Head E, Butterfield DA, Giorgi A, Schinina ME, Mancuso C, Cini C, Perluigi M
Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: Redox proteomics analysis of human brain.
Biochim Biophys Acta. 2013 Aug;1832(8):1249-59. PubMed: 23603808PAPER Brandt A, Vilcinskas A
The Fruit Fly Drosophila melanogaster as a Model for Aging Research.
Adv Biochem Eng Biotechnol. 2013 Apr 19; PubMed: 23604209PAPER Orre M, Kamphuis W, Dooves S, Kooijman L, Chan ET, Kirk CJ, Dimayuga Smith V, Koot S, Mamber C, Jansen AH, Ovaa H, Hol EM
Reactive glia show increased immunoproteasome activity in Alzheimer's disease.
Brain. 2013 May;136(Pt 5):1415-31. PubMed: 23604491PAPER Arnold SJ, Dugger BN, Beach TG
TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies.
Acta Neuropathol. 2013 Jul;126(1):51-7. PubMed: 23604587PAPER Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G, Geissen M, Eiden M, Leidel F, Hirschberger T, Deeg AA, Krauth JJ, Zinth W, Tavan P, Pilger J, Zweckstetter M, Frank T, Bähr M, Weishaupt JH, Uhr M, Urlaub H, Teichmann U, Samwer M, Bötzel K, Groschup M, Kretzschmar H, Griesinger C, Giese A
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
Acta Neuropathol. 2013 Jun;125(6):795-813. PubMed: 23604588PAPER Zhang C, Ren C, Chen H, Geng R, Fan H, Zhao H, Guo K, Geng D
The analog of Ginkgo biloba extract 761 is a protective factor of cognitive impairment induced by chronic fluorosis.
Biol Trace Elem Res. 2013 Jun;153(1-3):229-36. PubMed: 23605048PAPER Crowe SE, Ellis-Davies GC
In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration.
J Comp Neurol. 2013 Jul 1;521(10):Spc1. PubMed: 23605442PAPER Tóth ME, Szegedi V, Varga E, Juhász G, Horváth J, Borbély E, Csibrány B, Alföldi R, Lénárt N, Penke B, Sántha M
Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice.
Cell Stress Chaperones. 2013 Apr 21; PubMed: 23605646PAPER Levacic D, Peddareddygari LR, Nochlin D, Sharer LR, Grewal RP
Inclusion-body myositis associated with Alzheimer's disease.
Case Rep Med. 2013;2013:536231. PubMed: 23606855PAPER Mielke MM, Haughey NJ
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?
Clin Lipidol. 2012 Oct;7(5):525-536. PubMed: 23606909PAPER Jones EL, Mok K, Hanney M, Harold D, Sims R, Williams J, Ballard C
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
Neurobiol Aging. 2013 Oct;34(10):2441.e1-5. PubMed: 23601808PAPER Lim WL, Lam SM, Shui G, Mondal A, Ong D, Duan X, Creegan R, Martins IJ, Sharman MJ, Taddei K, Verdile G, Wenk MR, Martins RN
Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E ɛ3 and ɛ4 knock-in mice.
Neurobiol Aging. 2013 Sep;34(9):2217-24. PubMed: 23601809PAPER Faivre E, Hölscher C
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.
Alzheimers Res Ther. 2013 Apr 19;5(2):20. PubMed: 23601582PAPER Robles Bayón A, Gude Sampedro F, Torregrosa Quesada JM
Bradycardia in frontotemporal dementia.
Neurologia. 2013 Apr 16; PubMed: 23601757Current Filters
No filters selected